Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 October 2022 | Story NONSINDISO QWABE | Photo Rio Button
The Lowveld serotine bat, named Neoromicia hlandzeni
The Lowveld serotine bat, named Neoromicia hlandzeni.

Biological expeditions to the unexplored central highlands of Angola between 2016 and 2019 led to the discovery of a new tiny, white-thumbed bat species from Eswatini by Prof Peter John Taylor from the UFS Department of Zoology and Entomology and the Afromontane Research Unit (ARU), together with colleagues from the University of Eswatini (UNESWA) and other collaborators.

The bat species, named Neoromicia hlandzeni or the Lowveld serotine bat – after the Lowveld of Eswatini (eHlandzeni) – is the first new animal species to be discovered in Eswatini and given a siSwati name. The Lowveld serotine bat is tiny at four grams, has a distinctive white thumb pad, and occurs in Eswatini, South Africa, Zimbabwe, and Mozambique.

Bats make up a quarter of all mammalian biodiversity. With modern technology and the exploration of previously inaccessible regions of Africa, the rate of discovery of both animal and plant species is accelerating.

According to Prof Taylor, the Lowveld serotine bat is a new species to science. The specimen from which the species was named was collected in the lowlands of Eswatini in 2005. “Later collections of bats from the highlands of Angola, undertaken by myself and students, revealed the fact that the highland and lowland forms were actually different species. Since there was already a name for the highland bat, we needed to find a new name for the lowland bat from Eswatini and South Africa, hence it is called the Lowveld serotine bat,” he said.

The importance of integrative taxonomy, local collaboration, and biodiversity surveys

Prof Taylor is a research fellow of the National Geographic Okavango Wilderness Project, and the bat discovery took place during expeditions under the patronage of the Angolan government, the Wild Bird Trust, and the National Geographic Okavango Wilderness Project. He said the aim of the expedition was to explore the plants and animals of a wilderness area (the source of the Okavango) that had not been explored before.

The discovery also led to their paper being published in the scientific journal, the Zoological Journal of the Linnean Society, this month. 

The publication, titled Integrative taxonomic analysis of new collections from the central Angolan highlands resolves the taxonomy of African pipistrelloid bats on a continental scale, showcases the importance of integrative taxonomy, local collaboration, and biodiversity surveys, as the description of this exciting new species would not have been possible without comparative genetic and morphological material from new collections in the poorly sampled central highlands of Angola. 
Prof Peter Taylor with his students, Veli Mdluli and Alexandra Howard
Prof Peter Taylor with his students, Veli Mdluli and Alexandra Howard, working on bat research. Howard was one of the co-authors of the paper. (Photo: Supplied)

Afromontane regions as hotspots of bat speciation, diversity, and micro-endemism

Although Prof Taylor is the first author to describe this new species, the work was done with a multidisciplinary team of colleagues, students, and collaborators from the UFS, UNESWA, the University of Pretoria, the University of Venda, and Stellenbosch University, as well as the Durban Natural Science Museum and the Ditsong National Museum of Natural History, with support from the Angolan government, the Wild Bird Trust, and the National Geographic Okavango Wilderness Project. 
“Describing a new species is an arduous task that can take years from discovery to publication. All the enormous collective efforts have shown the importance of collaborative biodiversity exploration using old and modern technologies, as well as the African ownership of this discovery,” Prof Taylor said.

Three of Prof Taylor's previous and current PhD students – all of them South African women – were part of this discovery process and are co-authors of the paper. All 14 co-authors in the team are African. Prof Taylor said the discovery adds a new species to the total bat list of 125 species for Southern Africa – at number 126.

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept